Service

The “Jeju-type Anti-Aging Convergence Industry Development Forum” was successfully held online.

Signed a technology transfer contract with Repure Life Science, Yonsei University Health System, Ewha Womans University, and CHA University

Repure Life Science and Ewha Womans University College of Pharmacy signed an industry-university exchange agreement

2020 pharmaceutical & bio forum-post corona, turning crisis into opportunity

CEO Kim Yong-sang of Repure Life Science -

Korea Ministry of Food and Drug Safety R&D Webzine COVID-19 Special Issue

Participated in the 1st Promising Bio Venture·Startup Investment Forum in K-BD Group 2020

COVID-19 plasma treatment developed by immunoproteomics

COVID-19 blood intestinal drug development

Repure Life Science Signs Joint Research Agreement with Kyung Nam Biopharma and Yonsei Health System